Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 Analogs vs Nutrition Counseling in Psoriatic Arthritis
NCT07111494Phase 4Recruiting
- Sponsor
- Medical College of Wisconsin
- Start
- May 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in psoriatic arthritis (PsA) (2 arms), sponsored by Medical College of Wisconsin. Primary endpoints: Minimal Disease Activity at 24 weeks and Disease Activity in Psoriatic Arthritis Remission at 24 weeks. Started May 2026; status: recruiting.
02
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT07111494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07111494.